Hologic Current Valuation vs. Shares Owned By Insiders

HO1 Stock  EUR 69.00  1.00  1.47%   
Based on the measurements of profitability obtained from Hologic's financial statements, Hologic may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Hologic's ability to earn profits and add value for shareholders.
For Hologic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hologic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hologic utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hologic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hologic over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Hologic Shares Owned By Insiders vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Hologic's current stock value. Our valuation model uses many indicators to compare Hologic value to that of its competitors to determine the firm's financial worth.
Hologic is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in shares owned by insiders category among its peers . The ratio of Current Valuation to Shares Owned By Insiders for Hologic is about  25,003,810,677 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hologic's earnings, one of the primary drivers of an investment's value.

Hologic Current Valuation vs. Competition

Hologic is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Instruments & Supplies industry is currently estimated at about 126.25 Billion. Hologic retains roughly 18.25 Billion in current valuation claiming about 14% of all equities under Medical Instruments & Supplies industry.

Hologic Shares Owned By Insiders vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Hologic

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
18.25 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Hologic

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
0.73 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Hologic Shares Owned By Insiders Comparison

Hologic is currently under evaluation in shares owned by insiders category among its peers.

Hologic Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Hologic, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hologic will eventually generate negative long term returns. The profitability progress is the general direction of Hologic's change in net profit over the period of time. It can combine multiple indicators of Hologic, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany.

Hologic Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Hologic. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hologic position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hologic's important profitability drivers and their relationship over time.

Use Hologic in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hologic will appreciate offsetting losses from the drop in the long position's value.

Hologic Pair Trading

Hologic Pair Trading Analysis

The ability to find closely correlated positions to Hologic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hologic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hologic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hologic to buy it.
The correlation of Hologic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hologic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hologic moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hologic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Hologic position

In addition to having Hologic in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Single Stock ETFs Thematic Idea Now

Single Stock ETFs
Single Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Hologic Stock

When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Risk vs Return Analysis.
For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
To fully project Hologic's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hologic at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hologic's income statement, its balance sheet, and the statement of cash flows.
Potential Hologic investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Hologic investors may work on each financial statement separately, they are all related. The changes in Hologic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hologic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.